Paul Reider has followed Coherus BioSciences’ last biosimilar product out the door. | Paul Reider has followed Coherus ...

With a market cap of $149.1 billion, Amgen Inc. (AMGN) is renowned for its innovative human therapeutics across oncology, ...

During Q1 2025, pharmaceutical companies accelerated biosimilar expansion through strategic acquisitions and partnerships in ...

Intas Pharmaceuticals has completed its acquisition of the UDENYCA (pegfilgrastim-cbqv) business from Coherus BioSciences Inc ...

The development marks a key regulatory milestone for the company and reinforces investor confidence in Biocon’s growing biosimilar portfolio. The newly approved drug, JOBEVNE (bevacizumab-nwgd ...

The data showed no clinically meaningful differences between the biosimilar and the reference product in terms of safety, efficacy, immunogenicity and ...

The company already markets the biosimilar under the brand name Abeymy in Europe and Canada. Shreehas Tambe, CEO and Managing Director of Biocon Biologics, described the approval as a “significant ...

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd has received U.S. Food and Drug Administration (U.S. FDA) approval for its Jobevne™ (bevacizumab-nwgd), a biosimilar Bevacizumab for intravenous ...

The approval of JOBEVNE expands Biocon Biologics' biosimilar oncology portfolio in the United States, which also includes OGIVRI (Trastuzumab-dkst) and FULPHILA (Pegfilgrastim-jmdb). The Company ...

Biocon Biologics Ltd. markets Jobevne in Europe and Canada as Abevmy, with prior approvals in 2021. This approval is Biocon's seventh U.S. biosimilar, enhancing their oncology portfolio and commitment ...

Biocon Biologics has received the Food and Drug Administration’s green light for Jobevne (bevacizumab-nwgd), a biosimilar bevacizumab for intravenous use. Jobevne, which is a recombinant ...

JOBEVNE, a recombinant humanized monoclonal antibody used to treat several different types of cancer, is a biosimilar to the reference product Avastin ® (bevacizumab). JOBEVNE is a vascular ...